Complex Regional Pain Syndrome Medicine

New antibody maturation technique yields high-affinity Arginase 2 antibody

This post originally appeared on Medical Xpress.

Researchers at the Cancer Research UK-AstraZeneca Antibody Alliance Laboratory in Cambridge, UK, have pioneered the development of an innovative affinity maturation technique to generate an inhibitory, high-affinity antibody against Arginase 2 (ARG2), an enzyme implicated in major human diseases including cancer. Their findings are published in mAbs today (Thursday), following publication of the method in Proceedings of the National Academy of Sciences.

This post originally appeared on Medical Xpress.

Add Comment

Click here to post a comment